{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:55:53Z","timestamp":1771260953588,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81671549"],"award-info":[{"award-number":["No. 81671549"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81273266"],"award-info":[{"award-number":["No. 81273266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81272839"],"award-info":[{"award-number":["No. 81272839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81472401"],"award-info":[{"award-number":["No. 81472401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00432-017-2485-4","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T11:23:04Z","timestamp":1501154584000},"page":"2221-2233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Opa interacting protein 5 acts as an oncogene in bladder cancer"],"prefix":"10.1007","volume":"143","author":[{"given":"Xuefeng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianquan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jigen","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0313-4544","authenticated-orcid":false,"given":"Duangai","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"9","key":"2485_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10654-016-0138-6","volume":"31","author":"AH Al-Zalabani","year":"2016","unstructured":"Al-Zalabani AH, Stewart KF (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 31(9):811\u2013851. doi:\n                        10.1007\/s10654-016-0138-6","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"2485_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","volume":"66","author":"S Chavan","year":"2014","unstructured":"Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A (2014) International variations in bladder cancer incidence and mortality. Eur Urol 66(1):59\u201373. doi:\n                        10.1016\/j.eururo.2013.10.001","journal-title":"Eur Urol"},{"issue":"5","key":"2485_CR3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5483\/BMBRep.2010.43.5.349","volume":"43","author":"HK Chun","year":"2010","unstructured":"Chun HK, Chung KS, Kim HC, Kang JE, Kang MA, Kim JT, Choi EH, Jung KE, Kim MH, Song EY, Kim SY, Won M, Lee HG (2010) OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers. BMB Rep 43(5):349\u2013354","journal-title":"BMB Rep"},{"issue":"1","key":"2485_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bjc.2012.215","volume":"107","author":"L Dyrskjot","year":"2012","unstructured":"Dyrskjot L, Zieger K, Kissow Lildal T, Reinert T, Gruselle O, Coche T, Borre M, Orntoft TF (2012) Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma. Br J Cancer 107(1):116\u2013122. doi:\n                        10.1038\/bjc.2012.215","journal-title":"Br J Cancer"},{"issue":"4","key":"2485_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.18632\/oncotarget.950","volume":"4","author":"M Freitas","year":"2013","unstructured":"Freitas M, Malheiros S, Stavale JN, Biassi TP, Zamuner FT, de Souza Begnami M, Soares FA, Vettore AL (2013) Expression of cancer\/testis antigens is correlated with improved survival in glioblastoma. Oncotarget 4(4):636\u2013646. doi:\n                        10.18632\/oncotarget.950","journal-title":"Oncotarget"},{"issue":"7","key":"2485_CR6","first-page":"7786","volume":"8","author":"J Fu","year":"2015","unstructured":"Fu J, Luo B, Guo WW, Zhang QM, Shi L, Hu QP, Chen F, Xiao SW, Xie XX (2015) Down-regulation of cancer\/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro. Int J Clin Exp Pathol 8(7):7786\u20137797","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2485_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.devcel.2006.11.002","volume":"12","author":"Y Fujita","year":"2007","unstructured":"Fujita Y, Hayashi T, Kiyomitsu T, Toyoda Y, Kokubu A, Obuse C, Yanagida M (2007) Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. Dev Cell 12(1):17\u201330. doi:\n                        10.1016\/j.devcel.2006.11.002","journal-title":"Dev Cell"},{"key":"2485_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.188","author":"SA Funt","year":"2016","unstructured":"Funt SA, Rosenberg JE (2016) Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol. doi:\n                        10.1038\/nrclinonc.2016.188","journal-title":"Nat Rev Clin Oncol"},{"issue":"18","key":"2485_CR9","doi-asserted-by":"publisher","first-page":"15772","DOI":"10.18632\/oncotarget.4694","volume":"6","author":"MF Gjerstorff","year":"2015","unstructured":"Gjerstorff MF, Andersen MH, Ditzel HJ (2015) Oncogenic cancer\/testis antigens: prime candidates for immunotherapy. Oncotarget 6(18):15772\u201315787. doi:\n                        10.18632\/oncotarget.4694","journal-title":"Oncotarget"},{"issue":"8","key":"2485_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.acthis.2013.03.008","volume":"115","author":"M Gong","year":"2013","unstructured":"Gong M, Xu Y, Dong W, Guo G, Ni W, Wang Y, Wang Y, An R (2013) Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma. Acta Histochem 115(8):810\u2013815. doi:\n                        10.1016\/j.acthis.2013.03.008","journal-title":"Acta Histochem"},{"issue":"13","key":"2485_CR11","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1182\/blood-2006-01-023127","volume":"108","author":"J Greiner","year":"2006","unstructured":"Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A, Dohner K, Schlenk RF, Pollack JR, Dohner H, Bullinger L (2006) Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches. Blood 108(13):4109\u20134117. doi:\n                        10.1182\/blood-2006-01-023127","journal-title":"Blood"},{"issue":"2","key":"2485_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","volume":"6","author":"H Ikeda","year":"1997","unstructured":"Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6(2):199\u2013208","journal-title":"Immunity"},{"issue":"2","key":"2485_CR13","doi-asserted-by":"publisher","first-page":"e87661","DOI":"10.1371\/journal.pone.0087661","volume":"9","author":"K Inoue","year":"2014","unstructured":"Inoue K, Maeda N, Mori T, Sekimoto R, Tsushima Y, Matsuda K, Yamaoka M, Suganami T, Nishizawa H, Ogawa Y, Funahashi T, Shimomura I (2014) Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity. PLoS One 9(2):e87661. doi:\n                        10.1371\/journal.pone.0087661","journal-title":"PLoS One"},{"issue":"44","key":"2485_CR14","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1038\/sj.onc.1210466","volume":"26","author":"M Kanehira","year":"2007","unstructured":"Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T (2007) Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 26(44):6448\u20136455. doi:\n                        10.1038\/sj.onc.1210466","journal-title":"Oncogene"},{"issue":"1","key":"2485_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2013.11.058","volume":"443","author":"IS Kim","year":"2014","unstructured":"Kim IS, Lee M, Park JH, Jeon R, Baek SH, Kim KI (2014) betaTrCP-mediated ubiquitylation regulates protein stability of Mis18beta in a cell cycle-dependent manner. Biochem Biophys Res Commun 443(1):62\u201367. doi:\n                        10.1016\/j.bbrc.2013.11.058","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2485_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1349-7006.2011.02167.x","volume":"103","author":"J Koinuma","year":"2012","unstructured":"Koinuma J, Akiyama H, Fujita M, Hosokawa M, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y (2012) Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis. Cancer Sci 103(3):577\u2013586. doi:\n                        10.1111\/j.1349-7006.2011.02167.x","journal-title":"Cancer Sci"},{"issue":"8","key":"2485_CR17","first-page":"9522","volume":"8","author":"E Lerut","year":"2015","unstructured":"Lerut E, Van Poppel H, Joniau S, Gruselle O, Coche T, Therasse P (2015) Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics. Int J Clin Exp Pathol 8(8):9522\u20139532","journal-title":"Int J Clin Exp Pathol"},{"key":"2485_CR18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13790","author":"K Li","year":"2016","unstructured":"Li K, Guo Q, Yang J, Chen H, Hu K, Zhao J, Zheng S, Pang X, Zhou S, Dang Y, Li L (2016) FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway. Oncotarget. doi:\n                        10.18632\/oncotarget.13790","journal-title":"Oncotarget"},{"issue":"10","key":"2485_CR19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/ijc.27914","volume":"132","author":"C Mengus","year":"2013","unstructured":"Mengus C, Schultz-Thater E, Coulot J, Kastelan Z, Goluza E, Coric M, Spagnoli GC, Hudolin T (2013) MAGE-A10 cancer\/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas. Int J Cancer J Int du Cancer 132(10):2459\u20132463. doi:\n                        10.1002\/ijc.27914","journal-title":"Int J Cancer J Int du Cancer"},{"issue":"2","key":"2485_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/blc-150025","volume":"2","author":"A Mirza","year":"2016","unstructured":"Mirza A, Choudhury A (2016) Bladder preservation for muscle invasive bladder cancer. Bladder Cancer (Amsterdam, Netherlands) 2(2):151\u2013163. doi:\n                        10.3233\/blc-150025","journal-title":"Bladder Cancer (Amsterdam, Netherlands)"},{"issue":"Pt 5","key":"2485_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1242\/jcs.03390","volume":"120","author":"N Naetar","year":"2007","unstructured":"Naetar N, Hutter S, Dorner D, Dechat T, Korbei B, Gotzmann J, Beug H, Foisner R (2007) LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit. J Cell Sci 120(Pt 5):737\u2013747. doi:\n                        10.1242\/jcs.03390","journal-title":"J Cell Sci"},{"issue":"5","key":"2485_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.aogh.2014.09.013","volume":"80","author":"JK Oh","year":"2014","unstructured":"Oh JK, Weiderpass E (2014) Infection and cancer: global distribution and burden of diseases. Ann Glob Health 80(5):384\u2013392. doi:\n                        10.1016\/j.aogh.2014.09.013","journal-title":"Ann Glob Health"},{"key":"2485_CR23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13740","author":"J Qin","year":"2016","unstructured":"Qin J, Li D, Zhou Y, Xie S, Du X, Hao Z, Liu R, Liu X, Liu M, Zhou J (2016) Apoptosis-linked gene 2 promotes breast cancer growth and metastasis by regulating the cytoskeleton. Oncotarget. doi:\n                        10.18632\/oncotarget.13740","journal-title":"Oncotarget"},{"key":"2485_CR24","doi-asserted-by":"publisher","first-page":"38369","DOI":"10.1038\/srep38369","volume":"6","author":"A Russo","year":"2016","unstructured":"Russo A, Saide A, Cagliani R, Cantile M, Botti G, Russo G (2016) rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFkappaB upon 5-FU treatment. Sci Rep 6:38369. doi:\n                        10.1038\/srep38369","journal-title":"Sci Rep"},{"issue":"1","key":"2485_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10\u201329","journal-title":"CA Cancer J Clin"},{"key":"2485_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1476-4598-9-226","volume":"9","author":"F Wadelin","year":"2010","unstructured":"Wadelin F, Fulton J, McEwan PA, Spriggs KA, Emsley J, Heery DM (2010) Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia. Mol Cancer 9:226. doi:\n                        10.1186\/1476-4598-9-226","journal-title":"Mol Cancer"},{"issue":"1","key":"2485_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2958.1998.00670.x","volume":"27","author":"JM Williams","year":"1998","unstructured":"Williams JM, Chen GC, Zhu L, Rest RF (1998) Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth. Mol Microbiol 27(1):171\u2013186","journal-title":"Mol Microbiol"},{"issue":"17","key":"2485_CR28","doi-asserted-by":"publisher","first-page":"e759","DOI":"10.1097\/md.0000000000000759","volume":"94","author":"C Xu","year":"2015","unstructured":"Xu C, Zeng XT, Liu TZ, Zhang C, Yang ZH, Li S, Chen XY (2015) Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies. Medicine 94(17):e759. doi:\n                        10.1097\/md.0000000000000759","journal-title":"Medicine"},{"issue":"1","key":"2485_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12032-012-0368-8","volume":"30","author":"F Yazarloo","year":"2013","unstructured":"Yazarloo F, Shirkoohi R, Mobasheri MB, Emami A, Modarressi MH (2013) Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern. Med Oncol 30(1):368. doi:\n                        10.1007\/s12032-012-0368-8","journal-title":"Med Oncol"},{"key":"2485_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.12521","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yang Z, Ou J, Xia X, Zhi F, Cui J (2016) The F-box protein FBXL18 promotes glioma progression by promoting K63-linked ubiquitination of Akt. FEBS Lett. doi:\n                        10.1002\/1873-3468.12521","journal-title":"FEBS Lett"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-017-2485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-017-2485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T10:06:20Z","timestamp":1507889180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-017-2485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s00432-017-2485-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}